Dalbavancin Hydrochloride Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 500mg
Reference Brands: Dalvance (USA), Xydalba (EU/UK)
Category:
Antibiotics
Dalbavancin is a long-acting lipoglycopeptide antibiotic used for treating acute bacterial skin and skin structure infections (ABSSSI) caused by Gram-positive bacteria, including MRSA (Methicillin-resistant Staphylococcus aureus). It’s given as an intravenous infusion and is known for its long half-life, allowing once-weekly dosing.
Dalbavancin hydrochloride is available in Injection
and strengths such as 500mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Dalbavancin hydrochloride is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Dalbavancin hydrochloride can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing